Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Priority Review could shorten this to 6 months Realistic estimate: 2027 at the earliest for US commercial availability, assuming Lilly files in late 2026 For the most current trial status, see the TRIUMPH Phase 3 trials guide
But California and New York are NOT in the compact
It is unknown whether Tirzepatide causes such tumors, including medullary thyroid cancer, in humans
Activating the GIP (glucose-dependent insulinotropic polypeptide) receptors has a huge impact on decreasing food intake and increasing energy expenditure
US$ 20.02
US$ 21.03
US$ 23.62
US$ 29.20
US$ 29.85
US$ 29.06
US$ 24.43
